Livzon Pharmaceutical Group Inc. (SHE:000513)
China flag China · Delayed Price · Currency is CNY
34.55
+0.01 (0.03%)
Feb 3, 2026, 11:35 AM CST

SHE:000513 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21
28,01930,70428,29227,45632,30733,156
Market Cap Growth
-5.88%8.53%3.04%-15.02%-2.56%19.91%
Enterprise Value
22,29624,77322,70022,29727,11427,086
Last Close Price
34.5436.9332.8029.1934.7134.08
PE Ratio
14.4814.9014.4814.3818.1919.33
Forward PE
13.5215.8317.2516.3618.2821.60
PS Ratio
2.372.602.282.172.683.15
PB Ratio
1.822.061.921.842.262.43
P/TBV Ratio
2.102.302.102.082.562.82
P/FCF Ratio
11.0512.7511.6514.9854.4621.90
P/OCF Ratio
8.7710.318.719.9016.9815.35
PEG Ratio
-0.290.290.290.290.29
EV/Sales Ratio
1.882.101.831.772.252.58
EV/EBITDA Ratio
7.718.038.288.7011.5811.19
EV/EBIT Ratio
8.839.7711.8111.5414.1413.35
EV/FCF Ratio
8.7910.299.3512.1745.7117.89
Debt / Equity Ratio
0.260.270.280.240.190.14
Debt / EBITDA Ratio
1.361.281.501.401.140.80
Debt / FCF Ratio
1.551.651.711.984.541.27
Asset Turnover
0.480.480.500.540.560.55
Inventory Turnover
2.312.092.332.472.742.82
Quick Ratio
1.951.871.861.971.832.13
Current Ratio
2.252.152.132.302.122.40
Return on Equity (ROE)
16.43%15.53%12.78%13.37%13.97%16.45%
Return on Assets (ROA)
6.38%6.40%4.81%5.11%5.58%6.58%
Return on Invested Capital (ROIC)
26.24%26.92%19.70%20.64%25.12%33.56%
Return on Capital Employed (ROCE)
14.70%15.10%11.30%11.10%12.40%14.00%
Earnings Yield
7.65%6.71%6.91%6.95%5.50%5.17%
FCF Yield
9.05%7.85%8.58%6.67%1.84%4.57%
Dividend Yield
3.15%2.98%4.12%5.48%3.75%3.67%
Payout Ratio
48.57%65.03%81.36%83.33%70.81%64.14%
Buyback Yield / Dilution
2.91%1.10%0.56%0.04%0.25%-0.41%
Total Shareholder Return
6.06%4.08%4.68%5.52%4.00%3.26%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.